While China is a relative latecomer to the global pharma R&D party, some of the fastest pipeline growth is now coming out of the country, which for the first time also has several home-grown entries ranking among the world’s top 25 pharma companies by pipeline size.
“For the first time, we see not one, but two Chinese-headquartered companies have left the runway and entered the stratospheric...




![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)

